Loading…
Hosted by Unknown Host · 🇺🇸 US · EN · 74 episodes
Established thought leaders with verified media credentials.
JCO Precision Oncology Conversations podcasts features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they examine groundbreaking research in the world of precision oncology and learn how these advancements are redefining treatment protocols.The year's fellows summarize the top JCO Precision Oncology articles in the series, JCO PO Article Insights.
Unknown Host hosts JCO Precision Oncology Conversations, a health show with 74 episodes published.
In this episode of JCO PO: Article Insights, host Jiasen He summarizes the article, " Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors
JCO PO author Dr. Emily Miao at Mass General Brigham Cancer Institute shares insights into the JCO PO article, " Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and
In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, " Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms " by Dean C. Pavlick
JCO PO authors Dr. Matthew Campbell and Dr. Mohammad Moussa at The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, Texas, share insights into their article, " Efficacy of Immune Che
In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, " EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti–Epidermal Growth Factor Receptor–Based Therapy in Metastatic Colorec
JCO PO author Dr. Tejas Patil at University of Colorado Cancer Center shares insights into the JCO PO article, " CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Sol
In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, " Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes Analysis " bySwanton et al.
In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood
In this JCO Precision Oncology Article Insights episode, host Dr. Carolyn Lineen summaries the article, " Concordance of Oncotype DX Breast Recurrence Score Assay Results Between Paired Core Needle Biopsy and Surgical Ex
JCO PO author Dr. Foldi at UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine shares insights into the JCO PO article, " Personalized Circulating Tumor DNA Testing for Detection of Progression and
In this JCO Precision Oncology Article Insights episode, host Dr. Jiasen He summaries the article, " Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ
JCO PO author Dr. Wainberg at UCLA shares insights into the JCO PO article, "Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial." Host Dr. Ra
In this JCO Precision Oncology Article Insights episode, host Dr. Harold Nathan Tan summarizes " Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent
JCO PO author Dr. Shilpa Gupta at Cleveland Clinic Children's Hospital shares insights into her article, " Fibroblast Growth Factor Receptor 3 (FGFR3) Alteration Status and Outcomes on Immune Checkpoint Inhibitors (ICPI)
In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes " Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized " by Góes et al. published on September 10, 2025.
Authors Drs. Jessica Ross and Alissa Cooper share insights into their JCO PO article, " Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcino
In this episode of JCO PO Article Insights, host Dr. Jiasen He summarizes the article, " Somatic Mutation Profiles of Colorectal Cancer by Birth Cohort " by Gilad, et al published October 11, 2025. TRANSCRIPT Jiasen He:
JCO PO author Dr. Bryson Katona at the University of Pennsylvania Perelman School of Medicine shares insights into his article, " Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International
JCO PO author Dr. Asaf Maoz at Dana-Farber Cancer Institute shares insights into article, " Causes of Death Among Individuals with Lynch Syndrome in the Immunotherapy Era ." Host Dr. Rafeh Naqash and Dr. Maoz discuss the
In this JCO Precision Oncology Article Insights episode, Dr. Jiasen He summarizes JCO PO article " Synthetic Lethal Co-Mutations in DNA Damage Response Pathways Predict Response to Immunotherapy in Pan-Cancer " by Hua Zh
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
JCO Precision Oncology Conversations has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
JCO Precision Oncology Conversations is hosted by Unknown Host. The show is categorised under health (fitness) and has published 74 episodes.
JCO Precision Oncology Conversations has published 74 episodes.
JCO Precision Oncology Conversations regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
JCO Precision Oncology Conversations is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
JCO Precision Oncology Conversations hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of JCO Precision Oncology Conversations average 14 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates JCO Precision Oncology Conversations's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 2 days ago.